x
CME-Tagline

Part 2
Patients with Hepatitis B: Medical Comorbidities That Can Impact Treatment and Prompt the Provider to Switch, Q&A Session 2

CMEO Webcast

Premiere Date: Tuesday, June 15, 2021

This activity offers CE credit for:

  1. Pharmacists (ACPE)

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Wednesday, June 30, 2021

Faculty


Kimberly A. Forde, MD, PhD, MHS Kimberly A. Forde, MD, PhD, MHS (Moderator)
Associate Professor of Medicine
Section of Hepatology, Department of Medicine
Temple University Hospital, Lewis Katz School of Medicine
Philadelphia, PA

Christina M. Madison, PharmD, FCCP, AAHIVP Christina M. Madison, PharmD, FCCP, AAHIVP 
Founder and CEO, The Public Health Pharmacist, PLLC
Associate Professor of Pharmacy Practice
Roseman University of Health Sciences, College of Pharmacy
Las Vegas, NV

Statement of Need

As a result of often-delayed diagnosis and treatment, patients with Chronic Hepatitis B (CHB) are presenting at an older age and with more liver and non-liver comorbidities that can further complicate treatment. Keeping a watchful eye on patients’ use of over-the-counter medications, supplements, and prescription medications for comorbid disorders that may interact with their HBV antiviral treatment is imperative.

This CME Outfitters webcast focuses on how pharmacists can partner with patients to help them to better understand their HBV, as well as best practices for communicating and collaborating with health care professionals about patients’ HBV treatment plans, and how they might be impacted by medical comorbidities, in order to optimize patient outcomes.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Partner with patients with HBV and their HCPs to support therapeutic decision-making in the presence of renal and bone comorbidities

Financial Support

Supported by an educational grant from Gilead Sciences, Inc.

Target Audience

Pharmacists

Credit Information

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hours (0.10 CEUs) Universal Activity Number: Live: 0376-0000-21-084-L01-P

Type: application-based

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Forde has no disclosures to report.

Dr. Madison reports that she is on the speakers bureau for Gilead Sciences, Inc. and Janssen Therapeutics.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report

Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

WC2-041-061521-47